Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
1999-05-04
2004-02-17
Caputa, Anthony C. (Department: 1642)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C424S133100, C424S141100, C424S143100, C424S144100, C424S153100, C424S172100, C424S173100, C530S387100, C530S387300, C530S388100, C530S388150, C530S388200, C530S388700, C530S388730, C530S388750, C530S389100, C530S389600
Reexamination Certificate
active
06692743
ABSTRACT:
Natural killer cells (NK) play an important role in immune defenses by their capacity to kill tumour cells or infected cells through natural cytotoxicity or to kill antibody coated target cells by a mechanism referred as the antibody dependent cellular cytotoxicity (ADCC) (reviewed in 1) (Renard). This mechanism appears to involve crosslinking of the NK FC&ggr;RIIIa, rapid secretion of lytic factors (i.e., perforin/granzyme B) and expression of Fas-ligand which then triggers the apoptosis of targeted cells (2-9)(Vivier JI 91, Salcedo, Azzoni, Galandrini, Kanakaraj, Aramburu, Milella, Umera).
Although the mechanism of ADCC is well understood, little is known about the fate of the NK cells after the reaction and notably how the immune system regulates the activity of these cells functioning repeatedly after target cell lysis (10)(Ulberg). It was however recently demonstrated in vitro that some NK cells become inactivated and then died by apoptosis 24 to 48 hrs. after the ADCC reaction (11)(Jewett).
It has been demonstrated that Il-2 activated NK cells or LAK cells, but not naive NK cells undergo rapid apoptotic cell death after Fc&ggr;RIIIa (12)(Orthaldo), CD94 (13)(Ida) or CD2 (14)(Ida) cross-linking with an antireceptor antibody, or after engagement in cytolytic functions (15)(Taga 1996). This activation induced cell death (AICD) of NK cells, that was suggested to contribute to the end of immune response, seemed to be dependent on the expression of Fas-ligand (16)(Eishen) or c-myc (17)(Azzoni).
In this application, it is described that apoptosis of freshly isolated NK cells occurs when the cells are treated in vitro with a mAb of which the Fc portion binds to their FcR&ggr;IIIa and the antigen binding specificity to some CD2 or HLA class I membrane molecules. This apoptosis occurs rapidly, does not require RNA synthesis and is Fas/Fas-ligand independent.
REFERENCES:
patent: 5730979 (1998-03-01), Bazin et al.
patent: 5951983 (1999-09-01), Bazin et al.
Sulica et al., Divergent Effects of Fc gamma RIIIA on the functional activities of NK cells, European Journal of Immunology, 26, pp. 1199-1203y, 1996.
Bazin Herve
Latinne Dominique
Caputa Anthony C.
Holleran Anne L.
Lillie Raymond J.
Olstein Elliot M.
Universite Catholique de Louvain
LandOfFree
Apoptosis of naive human NK cells by crosslinking of their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apoptosis of naive human NK cells by crosslinking of their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apoptosis of naive human NK cells by crosslinking of their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3323843